Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Tax withholding / forfeiture | 4 | 4,607 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
37 Form 4 filings on record, the earliest from Nov 12, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Paul Blanchfield - Officer | Open-market sale | Common Stock | 3,060 | $53.57 | $164K | |
| Paul Blanchfield - Officer | Tax withholding / forfeiture | Common Stock | 518 | $81.26 | $42K | |
| Sam R. Leno - Director | Grant or award | Common Stock | 2,537 | $0.00 | - | |
| Sam R. Leno - Director | Grant or award | Stock Option (right to buy) | 4,543 | $0.00 | - | |
| Brian A. Markison - Officer | Option exercise | Common Stock | 16,102 | $12.42 | $200K | |
| Brian A. Markison - Officer | Option exercise | Common Stock | 16,666 | $6.00 | $100K | |
| Brian A. Markison - Officer | Tax withholding / forfeiture | Common Stock | 15,446 | $91.15 | $1.41M | |
| Brian A. Markison - Officer | Option exercise | Stock Option (right to buy) | 16,102 | $0.00 | - | |
| Brian A. Markison - Officer | Option exercise | Stock Option (right to buy) | 16,666 | $0.00 | - | |
| Robert J. Marshall Jr. - Officer | Open-market sale | Common Stock | 10,000 | $81.20 | $812K | |
| Paul Blanchfield - Officer | Open-market sale | Common Stock | 2,000 | $79.65 | $159K | |
| Paul Blanchfield - Officer | Gift | Common Stock | 355 | $0.00 | - | |
| Mary Anne Heino - Director | Open-market sale | Common Stock | 7,487 | $86.32 | $646K | |
| Mary Anne Heino - Director | Open-market sale | Common Stock | 400 | $86.93 | $35K | |
| Mary Anne Heino - Director | Open-market sale | Common Stock | 2,900 | $88.78 | $257K | |
| Mary Anne Heino - Director | Open-market sale | Common Stock | 700 | $89.58 | $63K |
This is as far as the anonymous view goes. Create a free account for all 37 LNTH filings on record.
Lantheus Holdings, Inc. (LNTH) had 4 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for LNTH runs to 37 Form 4 filings, the earliest from 2024-11-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of LNTH were filed in the last 90 days.
No insider sales of LNTH were filed in the last 90 days. 11 sales are on record for this company.
This page tracks LNTH Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add LNTH to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.